Abstract
Decreased heart rate variability (HRV) in critically ill patients indicates a poor prognosis. In heart failure patients, there is an elevated sympathetic tone, reflected by a dominance of sympathetic parameters in HRV, whereas in critically ill patients sympathetic and parasympathetic modulation of heart rate is attenuated despite increased catecholamine blood levels. Thus, autonomic dysfunction in the critically ill cannot be causally related to an impairment at the level of neural transmission, but may be due to a derangement of signal transduction at the effector cell level. On the basis of our working hypothesis that endotoxin may be involved in this blunting of effector cell response to nerval input, we studied the spontaneous beating of cardiomyocytes under the influence of endotoxin. Applying the clinically established indices of HRV to the analysis of beating rate variability (BRV) of neonatal rat cardiomyocytes in serum-free medium, a narrowing of their BRV by endotoxin is demonstrated. We propose that the narrowing of HRV in critically ill patients does not only reflect the altered input from the central or peripheral neurons, but rather a remodeling of the cardiac pacemaker cells by endotoxin and inflammatory mediators.
References
Nov 1, 1979·Circulation Research·J Jalife, G K Moe
Aug 1, 1991·Circulation·A MallianiS Cerutti
Jan 1, 1989·Methods in Enzymology·K Werdan, E Erdmann
Jan 10, 1985·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·D DiFrancesco, D Noble
Oct 1, 1995·Critical Care Medicine·B GoldsteinP D Woolf
Jul 1, 1996·Critical Care Medicine·P J Godin, T G Buchman
Jul 1, 1996·Critical Care Medicine·P J GodinA F Suffredini
Jul 1, 1996·Naunyn-Schmiedeberg's Archives of Pharmacology·C ReithmannK Werdan
Feb 1, 1997·Journal of Molecular and Cellular Cardiology·U Müller-WerdanK Werdan
Feb 28, 1998·Journal of Molecular and Cellular Cardiology·U Müller-WerdanK Werdan
Mar 20, 1998·Circulation Research·M UechiS F Vatner
Jun 10, 1998·Journal of Molecular and Cellular Cardiology·U Müller-WerdanK Werdan
Feb 17, 1999·Journal of Molecular and Cellular Cardiology·S YooY E Earm
Feb 17, 1999·Journal of Molecular and Cellular Cardiology·K L ComstockR A Sabbadini
Jul 13, 1999·Circulation Research·E Marbán
Jul 13, 1999·Circulation Research·W ShiI S Cohen
Oct 6, 1999·American Journal of Respiratory and Critical Care Medicine·N Abi-GergesP F Méry
Jun 13, 2000·Circulation Research·J P KuceraS Rohr
Jan 6, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·R BlunckU Seydel
Sep 9, 2005·Critical Care Medicine·Hendrik SchmidtKarl Werdan
Dec 20, 2007·Shock·Klaus Zorn-PaulyUrsula Müller-Werdan
Citations
Dec 4, 2012·Journal of Clinical Monitoring and Computing·Jeremy D ScheffIoannis P Androulakis
Mar 23, 2012·The Journal of Pharmacology and Experimental Therapeutics·Karthikeyan KrishnamurthyGovindasamy Ilangovan
Jun 25, 2010·American Journal of Physiology. Cell Physiology·Robert WondergemDavid L Williams
Aug 17, 2012·American Journal of Physiology. Cell Physiology·Robert WondergemDavid L Williams
Aug 7, 2009·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Karen D FairchildJ Randall Moorman
Dec 18, 2013·PloS One·Roham MazloomAli R Mani
Apr 17, 2009·Canadian Journal of Physiology and Pharmacology·Karl WerdanUrsula Müller-Werdan
Jun 6, 2009·Der Internist·K WerdanU Müller-Werdan
May 27, 2010·Der Internist·H Ebelt, K Werdan
Dec 22, 2015·Naunyn-Schmiedeberg's Archives of Pharmacology·Marwa Y SallamMahmoud M El-Mas
Dec 25, 2013·The Journal of Physiology·Udo KlöcknerMichael Gekle
May 2, 2015·Clinical and Experimental Pharmacology & Physiology·Henning EbeltHarald Loppnow
May 26, 2011·Journal of Molecular and Cellular Cardiology·Udo KlöcknerMichael Gekle
Apr 26, 2016·Journal of Cardiovascular Pharmacology·Marwa Y SallamMahmoud M El-Mas
Feb 1, 2014·Physiological Measurement·Roham MazloomAli R Mani
Jan 18, 2012·Shock·Masoumeh GholamiAli R Mani
Apr 2, 2016·Epidemiology·Richa AdhikariSara Dubowsky Adar